Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Patent tenofovir alafenamide gilead?
Defense strategy against generic in niche market?
Xenazine current manufacturer 2025?
Guselkumab brand name?
Diltiazem drug class?

Fentanyl pill price?

See the DrugPatentWatch profile for Fentanyl

Information regarding the specific price of fentanyl pills is not publicly available through standard drug pricing databases or publicly accessible sales data. Drug pricing is complex and influenced by various factors including manufacturer, dosage, formulation, pharmacy, insurance coverage, and geographic location.

What influences the price of prescription medications?


The price of prescription drugs is determined by a combination of factors. These include the costs associated with research and development, manufacturing, marketing, and distribution [1]. Additionally, patent protection and market exclusivity can significantly impact pricing, allowing manufacturers to set higher prices while their drugs are the sole option [2]. Pharmacy dispensing fees and agreements with insurance providers also play a role in the final cost to consumers [1].

When do drug patents expire?


Drug patents typically expire after 20 years from the date of filing the patent application [3]. However, the effective market exclusivity period can be extended through various mechanisms, such as patent term extensions granted to compensate for regulatory review delays [3]. The patent landscape for a specific drug can also be complex, involving multiple patents covering different aspects of the drug, such as its composition, method of use, or manufacturing process [4]. Information about specific drug patent expirations can often be found through specialized databases like DrugPatentWatch.com [4].

How do generic alternatives affect drug prices?


Once a brand-name drug's patent protection ends and generic versions become available, competition typically drives down prices significantly [2]. Generic drugs are bioequivalent to their brand-name counterparts but are manufactured by different companies, leading to more competitive pricing.

What are the risks associated with fentanyl?


Fentanyl is a potent synthetic opioid and carries significant risks, including a high potential for addiction and overdose [5]. Due to its potency, even small deviations in dosage can lead to life-threatening respiratory depression [5]. The illicit manufacturing and distribution of fentanyl have also led to a public health crisis characterized by widespread overdose deaths [6].

Where can I find more information on drug pricing and patents?


For detailed information on drug patents, exclusivity periods, and potential generic entry, resources such as DrugPatentWatch.com are available. These platforms can provide insights into the patent status and projected expiry dates for various medications [4].

Sources:

1. National Council on Patient Information and Education. (n.d.). Understanding Prescription Drug Costs.
2. Kele, P. P. (2004). The Economics of Pharmaceutical Pricing.
3. U.S. Food and Drug Administration. (n.d.). Hatch-Waxman Act: Patent Term Restoration.
4. DrugPatentWatch.com. (n.d.). Drug Patent Information. https://drugpatentwatch.com/
5. Centers for Disease Control and Prevention. (n.d.). About Fentanyl.
6. National Institute on Drug Abuse. (n.d.). Fentanyl: The Drug and the Crisis.



Other Questions About Fentanyl :

fentanyl 100mcg/2ml vl Fentanyl patch street price? Fentanyl actavis 100? How much does fentanyl cost? Fentanyl patch 100 mcg? Fentanyl ingredients? Fentanyl patch price philippines?

AI-Drug Label Prescribing Information Alignment Report

100
100%
Grade A

Excellent

Mostly Aligned

Patient Risk: Low

Summary

All evaluated claims in the provided list are directly supported by the supplied FDA label excerpts (Sections 5.1 and 5.2). No contradictions were found for the claims actually assessed.

Category Scores

Indication
100
Excellent
Indication
100
Excellent
Indication
100
Excellent
Indication
100
Excellent

Accurate Statements

Fentanyl transdermal system exposes users to risks of addiction, abuse, and misuse as an opioid (Schedule II).
Section 5.1: “...contains fentanyl, an opioid agonist and a Schedule II controlled substance. As an opioid, fentanyl transdermal system exposes users to the risks of addiction, abuse, and misuse.”
Addiction can occur even at recommended doses and the risk persists over the course of therapy.
Section 5.1: “Addiction can occur at recommended doses ... The risk of opioid-related overdose or overdose-related death is increased with higher opioid doses, and this risk persists over the course of therapy.”
Serious, life-threatening, or fatal respiratory depression has been reported with opioids even when used as recommended.
Section 5.2: “Serious, life-threatening, or fatal respiratory depression has been reported with the use of opioids, even when used as recommended.”
Fentanyl transdermal system is indicated only in opioid-tolerant patients due to risk of respiratory depression and death.
Section 5.2: “Fentanyl transdermal system is indicated only in opioid tolerant patients because of the risk for respiratory depression and death.”
The risk of respiratory depression is greatest during initiation or after a dosage increase.
Section 5.2: “...the risk is greatest during the initiation of therapy or following a dosage increase.”
Accidental exposure, especially in children, can result in respiratory depression and death due to overdose.
Section 5.2: “Accidental exposure to fentanyl transdermal system, especially in children, can result in respiratory depression and death due to an overdose of fentanyl.”

Unsupported Statements

Contradictions

Important Omissions

No evaluation was provided for many other label elements (e.g., boxed warning content specifics, contraindications, detailed dosage/administration, adverse reactions, monitoring, storage/handling).
Importance: Moderate

Safety Assessment

Potential Patient Risk: Low
The assessed statements are risk-warning content that is consistent with the provided label sections (5.1, 5.2), and no contradictions or unsupported safety claims were identified within the evaluated set.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Mostly Aligned

Primary Issue
Only a subset of the user’s listed claims was evaluated against the label excerpts (sections 5.1 and 5.2). Other FDA-label topics were not assessed due to lack of corresponding claims and/or label text in the prompt.

Suggested Improvement
Provide the full AI response content intended for auditing and the corresponding FDA label sections (e.g., boxed warning text, contraindications, dosage/administration, adverse reactions, monitoring, drug interactions) so all statements can be evaluated claim-by-claim.

Drug Brand Mention Assessment

Branding Score
13
Visibility
16
Mentioned
Ranking
#1
Sentiment
25
Recommendation Status
mentioned only
Brand Perception
Best Known For

a potent synthetic opioid

Core Claims
  • Information regarding the specific price of fentanyl pills is not publicly available through standard drug pricing databases or publicly accessible sales data.
  • Fentanyl is a potent synthetic opioid and carries significant risks, including a high potential for addiction and overdose.
  • Even small deviations in dosage can lead to life-threatening respiratory depression.
  • The illicit manufacturing and distribution of fentanyl have led to a public health crisis characterized by widespread overdose deaths.
Differentiators
Pricing Perception: Not Mentioned